Search results

Four years after the tragic earthquake, Haitian national institutions, civil society, communities and citizens are leading reconstruction and development in the country.

21 humanitarian and human rights organizations say warring parties and powerful states have failed to implement UNSC resolutions leading to “worst year” of crisis for civilians in Syria.

EU leaders must live up to their commitments to European values in responding to migration and stop copying xenophobic populist recipes, more than 170 NGOs said today in a joint statement.

The Greek government, with the support of EU member states, should act now to end Greece’s “containment policy,” 20 human rights and aid groups said today. The policy forces asylum seekers arriving on the Greek islands to remain in overcrowded, unsafe facilities, an urgent concern with winter approaching.

Development NGOs Oxfam, ONE and Plan international welcomed a European Parliament vote to reject proposed cuts and to increase of the EU's external spending, supporting for the fight to end extreme poverty.

Oxfam India’s CEO Nisha Agrawal is in the UK this week to mark 60 years of Oxfam working in India, responding to emergencies and helping to pull millions of people out of poverty.

A major diplomatic negotiation aiming to regulate the trade in weapons and ammunition is at risk of failing due to member states’ insistence to give every state the right to veto a future treaty, according to the Control Arms coalition.

Hundreds of thousands of poor people will go without life-saving medicines and many more children will miss out on school because of the first cuts in aid since 1997, Oxfam warned today.

Faltering overseas aid figures announced today are depriving poor countries of a massive $18bn worth of life-saving aid, at a time when 64 million more people globally have been pushed into poverty by the financial crisis.

New Oxfam report: The proliferation of substandard medicines in poor countries is being used by rich countries as an excuse to tighten intellectual property rules, boosting the profits of large pharmaceutical companies while making it harder for poor people to get access to the medicines they need.